Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olli Kallioniemi

Showing results (71-80 of 184) with videos related to

Pageof 19
Sort By:
Lung Cancer (Amsterdam, Netherlands)|March 6, 2023
Novel therapeutic approaches for pleural mesothelioma identified by functional ex vivo drug sensitivity testingHely Ollila-Raj, Astrid Murumägi, Teijo Pellinen, et al.
Molecular Oncology|May 24, 2025
Systematic profiling of cancer-fibroblast interactions reveals drug combinations in ovarian cancerGreta Gudoityte, Osheen Sharma, Laura Leuenberger, et al.
Nature|December 2, 2016
Consistency in drug response profilingJohn Patrick Mpindi, Bhagwan Yadav, Päivi Östling, et al.
Cell Death & Disease|April 23, 2025
Mechanisms of chemotherapy failure in refractory/relapsed acute myeloid leukemia: the role of cytarabine resistance and mitochondrial metabolismSoo Yeon Chae, Se-Young Jang, Jinhui Kim, et al.
Blood Advances|January 4, 2018
Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphomaHanna Karvonen, David Chiron, Wilhelmiina Niininen, et al.
Experimental Cell Research|December 26, 2009
Interactions between Notch- and hypoxia-induced transcriptomes in embryonic stem cellsHeather Main, Kian Leong Lee, Henry Yang, et al.
The Journal of Pathology|November 11, 2011
15-Hydroxyprostaglandin dehydrogenase associates with poor prognosis in breast cancer, induces epithelial-mesenchymal transition, and promotes cell migration in cultured breast cancer cellsLaura Lehtinen, Paula Vainio, Harriet Wikman, et al.
The Journal of Pathology. Clinical Research|October 26, 2018
Combined epithelial marker analysis of tumour budding in stage II colorectal cancerKhadija Slik, Sami Blom, Riku Turkki, et al.
International Journal of Cancer|May 3, 2008
Functional evidence implicating S100P in prostate cancer progressionGargi D Basu, David O Azorsa, Jeffrey A Kiefer, et al.
Cancer Research Communications|March 6, 2023
Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate CancerTeijo Pellinen, Kevin Sandeman, Sami Blom, et al.
Pageof 19

Showing results (71-80 of 184) with videos related to

Sort By:
Pageof 19
Lung Cancer (Amsterdam, Netherlands)|March 6, 2023
Novel therapeutic approaches for pleural mesothelioma identified by functional ex vivo drug sensitivity testingHely Ollila-Raj, Astrid Murumägi, Teijo Pellinen, et al.
Molecular Oncology|May 24, 2025
Systematic profiling of cancer-fibroblast interactions reveals drug combinations in ovarian cancerGreta Gudoityte, Osheen Sharma, Laura Leuenberger, et al.
Nature|December 2, 2016
Consistency in drug response profilingJohn Patrick Mpindi, Bhagwan Yadav, Päivi Östling, et al.
Cell Death & Disease|April 23, 2025
Mechanisms of chemotherapy failure in refractory/relapsed acute myeloid leukemia: the role of cytarabine resistance and mitochondrial metabolismSoo Yeon Chae, Se-Young Jang, Jinhui Kim, et al.
Blood Advances|January 4, 2018
Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphomaHanna Karvonen, David Chiron, Wilhelmiina Niininen, et al.
Experimental Cell Research|December 26, 2009
Interactions between Notch- and hypoxia-induced transcriptomes in embryonic stem cellsHeather Main, Kian Leong Lee, Henry Yang, et al.
The Journal of Pathology|November 11, 2011
15-Hydroxyprostaglandin dehydrogenase associates with poor prognosis in breast cancer, induces epithelial-mesenchymal transition, and promotes cell migration in cultured breast cancer cellsLaura Lehtinen, Paula Vainio, Harriet Wikman, et al.
The Journal of Pathology. Clinical Research|October 26, 2018
Combined epithelial marker analysis of tumour budding in stage II colorectal cancerKhadija Slik, Sami Blom, Riku Turkki, et al.
International Journal of Cancer|May 3, 2008
Functional evidence implicating S100P in prostate cancer progressionGargi D Basu, David O Azorsa, Jeffrey A Kiefer, et al.
Cancer Research Communications|March 6, 2023
Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate CancerTeijo Pellinen, Kevin Sandeman, Sami Blom, et al.
Pageof 19